Skip to main content
Bioton S.A. logo

Bioton S.A. — Investor Relations & Filings

Ticker · BIO ISIN · PLBIOTN00029 LEI · 259400I5R1L3OPCGII81 WAR Manufacturing
Open in API
Filings indexed 697 across all filing types
Latest filing 2016-07-28 Regulatory Filings
Country PL Poland
Listing WAR BIO

About Bioton S.A.

https://bioton.com/en/

Bioton S.A. is a biotechnology company focused on providing comprehensive solutions for diabetes care. The company's core activity is the development and production of recombinant human insulin, positioning it as a significant commercial manufacturer globally. Its operations cover the full biotechnological process, from DNA research and development to the manufacturing and marketing of finished medicinal products. The product portfolio is centered on various forms of insulin and is complemented by modern automatic injection systems designed to facilitate effective diabetes treatment for patients.

Recent filings

Filing Released Lang Actions
Przesuniecie terminu spełnienia kolejnych warunków porozumienia w sprawie rozwiązania umów z Grupą BIOTEC OOO - Content (PL)
Regulatory Filings Classification · 95% confidence The document text is very short (950 characters) and discusses an update regarding the fulfillment of terms within a prior agreement ('Porozumienie Biotec') between BIOTON S.A. and another entity, specifically postponing payment deadlines and security provision deadlines. This type of specific, material event disclosure, often related to legal or contractual obligations, fits best under the general category for regulatory announcements that are not specifically covered by other detailed forms like 10-K, ER, or DIV. Since it is a specific update on a contractual/financial matter that doesn't fit ER, IR, CAP, or LTR precisely, and given its brevity suggesting it's an announcement rather than a full report, the most appropriate fallback is Regulatory Filings (RNS).
2016-07-28 Polish
Spełnienie warunku porozumienia w sprawie rozwiązania umów z Grupą BIOTEC OOO - Content (PL)
Regulatory Filings Classification · 95% confidence The document text is a continuation or update ('W nawiązaniu do raportu bieżącego...') regarding a previous agreement ('Porozumienie Biotec') concerning the transfer of registration certificates for insulin products in the Russian Federation. It details the fulfillment of one condition and the rescheduling of two other conditions (payment and security for overdue liabilities). This type of communication, which updates the market on specific contractual or legal developments, fits best under the general category for regulatory announcements that are not standard financial reports (10-K, IR, ER) or specific insider/dividend actions. Since it is an update on a significant business/legal matter (resolution of prior agreements, transfer of assets/rights), and it is not a standard financial report, it is classified as a Regulatory Filing (RNS), which serves as the general category for miscellaneous regulatory announcements.
2016-07-25 Polish
Zawarcie porozumienia w sprawie rozwiązania umów z Grupą BIOTEC OOO oraz zawarcie umowy z Grupą Pharmasyntez – Tyumen OOO w sprawie sprzedaży insulin BIOTON S.A. w Federacji Rosyjskiej - Content (PL)
Legal Proceedings Report Classification · 99% confidence The document is a formal announcement in Polish by BIOTON S.A. detailing the termination of previous distribution agreements with BIOTEC OOO and the simultaneous signing of a new, exclusive distribution and manufacturing agreement with Pharmasyntez OOO for the Russian Federation, Kazakhstan, and Kyrgyzstan. It discusses specific financial obligations, contingent conditions (like the transfer of registration certificates), and projected sales volumes. This type of disclosure, concerning significant commercial contracts, regulatory transfers, and related financial implications, is characteristic of a material event disclosure. Since it is not a full annual report (10-K), a quarterly report (IR), an earnings release (ER), or a management discussion (MDA), and it relates to a major business transaction (new distribution/licensing deal), it fits best under the general category for significant corporate actions or regulatory disclosures. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for a material, non-standardized corporate event announcement, although it strongly relates to business operations and potential future revenue. However, since it details a major transaction (new distribution agreement) and the termination of an old one, it is a significant corporate event disclosure. In many regulatory contexts, such material business updates are filed as current reports. Since there isn't a specific 'Material Event Disclosure' code, RNS (Regulatory Filings) serves as the best fit for this type of mandatory, non-periodic announcement.
2016-07-19 Polish
Zawiadomienie Bimeda Holding Ltd o rezygnacji z zamiaru zwiększenia udziału w BIOTON S.A. - Content (PL)
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document text is very short (688 characters) and appears to be a regulatory notification in Polish concerning a change in intent regarding the acquisition of voting rights by a major shareholder (Fundusz/Basolma). Specifically, it mentions a withdrawal of the intention to increase the shareholding to a certain percentage (30%-33%) within the next 12 months, referencing previous reports. This type of notification about changes in significant share ownership thresholds or intentions falls under the category of Major Shareholding Notification (MRQ). Since the text is a brief announcement about a change in ownership intent rather than a full report, MRQ is the most appropriate classification.
2016-07-18 Polish
Podział funkcji w Radzie Nadzorczej BIOTON S.A. - Content (PL)
Board/Management Information Classification · 98% confidence The document text is very short (628 characters) and announces specific changes within the company's supervisory board (Rada Nadzorcza). It details the appointment of new members (Jubo Liu, David Martin Comberbach, Dariusz Trzeciak) and the delegation of supervisory roles. This content directly relates to changes in the composition of the board of directors or senior management, matching the definition for Board/Management Information (MANG). It is not a full report, a dividend notice, or a general regulatory filing.
2016-06-29 Polish
RB_2016_33.pdf
Board/Management Information Classification · 98% confidence The document text is a formal announcement from BIOTON S.A. detailing the appointment of new members to its Supervisory Board ('Rada Nadzorcza') following the Annual General Meeting ('Zwyczajne Walne Zgromadzenie') held on 28.06.2016. It provides extensive biographical details for each newly appointed member (Jubo Liu, Dariusz Trzeciak, etc.). This content directly relates to changes in the company's governing body (Board of Directors/Supervisory Board). Therefore, the appropriate classification is Board/Management Information (MANG).
2016-06-29 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.